After the transaction, Antfin Singapore Holding, which formerly owned a 4.3% share in Zomato, would be subject to a 90-day lock-in period before it may further reduce its equity. On Tuesday, Zomato’s shares, valued at Rs 5,438.50 crore, were sold in a block deal that was later expanded. A report published by Moneycontrol states that […]
Zomato sees a block offer for 21 crore shares valued at Rs 5,438 crore Read More »
Copper scrap is recycled by Sunlite Recycling, which specializes in producing copper rods, wires, earthing wires, earthing strips, conductors, and wire rods. On August 20, Sunlite Recycling Industries’ shares made a strong debut on the stock market. At that time, the share price was Rs 199.5, which was ninety percent more than the issue price
Shares of Sunlite Recycling Industries list for 90% more than their IPO price Read More »
Tuesday saw gains in the majority of Asian stocks, following Wall Street’s overnight surge as investors welcomed the possibility of a reduction in US interest rates ahead of Federal Reserve Chair Jerome Powell’s major speech later this week. However, as the People’s Bank maintained its benchmark loan prime rate steady as anticipated, surprising some traders
A fresh contender is presenting a substitute proposal for the media behemoth Paramount Global. Edgar Bronfman Jr., a media investor and US billionaire, made a US$4.3 billion bid to purchase National Amusements, owned by Shari Redstone. The Wall Street Journal broke this story initially on Monday, August 19. According to media sources, the plan calls
Edgar Bronfman offers $4.3 billion to Paramount and National Amusements Read More »
A major player in the metal industry, Vedanta Limited announced on Friday that it would employ the oversubscription option in Hindustan Zinc Limited’s ongoing offer for sale (issue) to the extent of over 1.21 crore equity shares, or 0.29%, in addition to the 5.14 crore equity shares, which represent 1.22% of the company’s total issued
Hindustan Zinc OFS: Vedanta Plans To Exercise Its Subscription Option Read More »
Pierre Fabre Laboratories has received a put option offer from Jubilant Biosys Innovative Research Services Pte Limited, Singapore, a division of Jubilant Biosys Limited, a fully owned subsidiary of Jubilant Pharmova Limited. The acquisition of an 80% stock part in a new firm to be founded in France is proposed in this offer, which would
Jubilant Pharmova To Invest In MNC Pierre Fabre’s French R&D Centre Via New Unit Read More »
August saw a persistent sell-off by foreign investors in the Indian equities markets, unloading shares valued at Rs 21,201 crore as a result of the termination of the yen carry trade, US recession worries, and ongoing geopolitical tensions. According to data from the depositories, this followed inflows of Rs 26,565 crore in June and Rs
In August, FPIs Turned Net Sellers, And Drew Out ₹21,201 Cr From Stocks Read More »
In India, exchange-traded funds, or ETFs, are becoming more popular. As of July 30, 2024, the assets under management (AUM) in exchange-traded funds (ETFs) had increased to Rs 8.11 trillion from Rs 1.88 trillion on February 29, 2020. Individual investor participation is also increasing, even though many readers will soon point out that this jump
How ETFs Are A Useful Tool For Investors And Positional Traders Read More »
Recent claims made by Hindenburg Research have raised questions about India’s regulatory environment and severely damaged the reputation of the Securities and Exchange Board of India (SEBI). This issue raises concerns about possible political repercussions within the largest democracy in the world, in addition to regulatory scrutiny. Reputed for its scathing analyses of big business,
Hindenburg Intensifies Its Assault Against Adani Read More »
The Indian market, according to a research by Kotak Institutional Equities dated May 31, is a mixture of “rightful optimism and mistaken euphoria.” Some industries demonstrate the robustness and steady expansion of the Indian economy, while others exhibit “extreme euphoria based on unfounded narratives.” In its most recent note, Kotak Institutional Equities stated that it
We strongly advise against making investment decisions based solely on the target prices mentioned on this website. These target prices are merely predictions, and investing in the stock market inherently involves risk. The information provided on this site is intended for informational and educational purposes only and should not be considered financial advice or recommendations for any stock.